Company: BLCO
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001860742-25-000008
Chunk: 98

Company: Bausch & Lomb Corp
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 2
Chunk 98
---
 our Annual Report, for additional information on the risks associated with our intellectual property and our competition risks.RESULTS OF OPERATIONSOur unaudited operating results for the three months ended March 31, 2025 and 2024 were as follows:Three Months EndedMarch 31,(in millions)20252024ChangeRevenuesProduct sales$1,133 $1,094 $39 Other revenues4 5 (1)1,137 1,099 38 ExpensesCost of goods sold (excluding amortization and impairments of intangible assets)481 423 58 Cost of other revenues1 1 — Selling, general and administrative (Note 4)563 504 59 Research and development86 82 4 Amortization of intangible assets67 74 (7)Other expense, net22 9 13 1,220 1,093 127 Operating (loss) income(83)6 (89)Interest income3 3 — Interest expense(94)(99)5 Foreign exchange and other(6)— (6)Loss before provision for income taxes(180)(90)(90)Provision for income taxes(31)(73)42 Net loss(211)(163)(48)Net income attributable to noncontrolling interest(1)(4)3 Net loss attributable to Bausch + Lomb Corporation$(212)$(167)$(45)

34

Three Months Ended March 31, 2025 Compared to the Three Months Ended March 31, 2024Revenues Our revenues are primarily generated from product sales in the therapeutic areas of eye health that consist of: (i) branded prescription eye-medications and pharmaceuticals, (ii) generic and branded generic prescription eye medications and pharmaceuticals, (iii) OTC vitamin and supplement products and (iv) medical devices (contact lenses, IOLs and ophthalmic surgical equipment). Other revenues include alliance and service revenue from the licensing and co-promotion of products and contract service revenue. Contract service revenue is derived primarily from contract manufacturing for third parties and is not material. See Note 17, “SEGMENT INFORMATION” to our unaudited interim Condensed Consolidated Financial Statements for the disaggregation of revenues which depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by the economic factors of each category of customer contracts.Our revenues were $1,137 million and $1,099